Dr. Daniel Favre
Dr. Daniel Favre, PhD’2023 (currently a Research Scientist at Bristol Myers Squibb (New Brunswick, NJ)
Dissertation title: High Resolution Mass Spectrometry as a Platform for the Analysis of Polyoxometalates, their Solution Phase Dynamics, and their Biological Interactions
Representative publications:
- D. Favre, J.F. Harmon, A. Zhang, M.S. Miller, I.A. Kaltashov. Decavanadate interactions with the elements of the SARS-CoV-2 spike protein highlight the potential role of electrostatics in disrupting the infectivity cycle. J. Inorg. Biochem. 2022, 234, 111899
- D. Favre, C.E. Bobst, S.J. Eyles, H. Murakami, D.C. Crans and I.A. Kaltashov. Solution- and gas-phase behavior of decavanadate: implications for mass spectrometric analysis of redox-active polyoxidometalates. Inorg. Chem. Front. 2022, 9, 1556-1564
Click here to see all papers co-authored by Dr. Favre based on his work at UMass-Amherst